<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H4B23715F3C964DACB7052A18F40377B0" public-private="public"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 1130 IH: Chronic Kidney Disease Improvement in Research and Treatment Act of 2015</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2015-02-26</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code> 
<congress>114th CONGRESS</congress> <session>1st Session</session> 
<legis-num>H. R. 1130</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20150226">February 26, 2015</action-date> 
<action-desc><sponsor name-id="M001179">Mr. Marino</sponsor> (for himself, <cosponsor name-id="L000287">Mr. Lewis</cosponsor>, and <cosponsor name-id="R000580">Mr. Roskam</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc> 
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes.</official-title> 
</form> 
<legis-body id="HA9155967CFA24FC0BD6575636F519A0F" style="OLC"> 
<section id="HF4CBD2749C5C4A7D84734271D90B170B" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Chronic Kidney Disease Improvement in Research and Treatment Act of 2015</short-title></quote>.</text> </section> <section id="H2AFF191900274BFE849F7B17C8892D54"><enum>2.</enum><header>Table of contents</header><text display-inline="no-display-inline">The table of contents of this Act is as follows:</text> 
<toc container-level="legis-body-container" lowest-bolded-level="division-lowest-bolded" lowest-level="section" quoted-block="no-quoted-block" regeneration="yes-regeneration"> 
<toc-entry idref="HF4CBD2749C5C4A7D84734271D90B170B" level="section">Sec. 1. Short title.</toc-entry> 
<toc-entry idref="H2AFF191900274BFE849F7B17C8892D54" level="section">Sec. 2. Table of contents.</toc-entry> 
<toc-entry idref="HAE92753E9F69499CB81B1388B4528631" level="title">Title I—Improving Understanding of Chronic Kidney Disease through Expanded Research and Coordination</toc-entry> 
<toc-entry idref="H55463BD7B7FC46F584A828734509DD22" level="section">Sec. 101. Identifying gaps in chronic kidney disease research.</toc-entry> 
<toc-entry idref="HCB71C16B08C141838F33FAEDCD9C0C0E" level="section">Sec. 102. Coordinating research on chronic kidney disease.</toc-entry> 
<toc-entry idref="H9FE9A2C2D01443499BFA14E38605328F" level="section">Sec. 103. Understanding the progression of kidney disease and treatment of kidney failure in minority populations.</toc-entry> 
<toc-entry idref="HB190DA462D7A480085BA72AECC1CA9D2" level="title">Title II—Promoting Access to Chronic Kidney Disease Treatments</toc-entry> 
<toc-entry idref="H47BF2D6CEEB74012B29352667B64C832" level="section">Sec. 201. Increasing access to Medicare kidney disease education benefit.</toc-entry> 
<toc-entry idref="HF1361AB34784472F853ABEF7E766EFB6" level="section">Sec. 202. Improving access to chronic kidney disease treatment in underserved rural and urban areas.</toc-entry> 
<toc-entry idref="H01827EC474C447CABDD754693EFF1E6D" level="section">Sec. 203. Promoting access to home dialysis treatments.</toc-entry> 
<toc-entry idref="H5DE5E78662404F4FA16D378377C4680C" level="section">Sec. 204. Expand access for patients with acute kidney injury.</toc-entry> 
<toc-entry idref="HF261E365714144ADA06149CA205790B0" level="title">Title III—Creating Economic Stability for Providers Caring for Individuals with Chronic Kidney Disease</toc-entry> 
<toc-entry idref="HFA655311481247E2A83F152523A2EBA6" level="section">Sec. 301. Stabilizing Medicare payments for services provided to beneficiaries with stage V chronic kidney disease receiving dialysis services.</toc-entry> 
<toc-entry idref="HE0222993C55A4EABA12784CFA1546340" level="section">Sec. 302. Allowing individuals with kidney failure to retain access to private insurance.</toc-entry> 
<toc-entry idref="HBBFC4F6A05EA49EC94082F0B4473FBE7" level="section">Sec. 303. Providing individuals with kidney failure access to managed care and coordinated care programs.</toc-entry></toc> </section>
<title id="HAE92753E9F69499CB81B1388B4528631"><enum>I</enum><header>Improving Understanding of Chronic Kidney Disease through Expanded Research and Coordination</header> 
<section id="H55463BD7B7FC46F584A828734509DD22"><enum>101.</enum><header>Identifying gaps in chronic kidney disease research</header> 
<subsection id="H45E9E177C23D4AFA8F572375A9B2647E"><enum>(a)</enum><header>Report</header><text>Not later than one year after the date of enactment of this Act, the Comptroller General of the United States shall develop and submit to the Congress a comprehensive report assessing the adequacy of Federal expenditures in chronic kidney disease research relative to Federal expenditures for chronic kidney disease care.</text> </subsection> <subsection id="HA06F54360DE745DFA1F0CCF749B11F6B"><enum>(b)</enum><header>Contents</header><text>The report required by this section shall—</text> 
<paragraph id="H58E763385CCA40D2974B800C7D361716"><enum>(1)</enum><text>analyze the current chronic kidney disease research projects being funded by Federal agencies;</text> </paragraph> <paragraph id="H11AEAB7180E842699F1367D36ECE6285"><enum>(2)</enum><text>identify, including by surveying the kidney care community, areas of chronic kidney disease knowledge gaps that are not part of current Federal research efforts;</text> </paragraph>
<paragraph id="HC60440CDE6154467A9A12951D6264353"><enum>(3)</enum><text>report on the level of Federal expenditures on kidney research as compared to the amount of Federal expenditures on treating individuals with chronic kidney disease; and</text> </paragraph> <paragraph id="H1C4A0D85E4D841BA90BED5E49D14F7B2"><enum>(4)</enum><text>identify areas of kidney failure knowledge gaps in research to assess treatment patterns associated with providing care to minority populations that are disproportionately affected by kidney failure.</text> </paragraph></subsection></section>
<section id="HCB71C16B08C141838F33FAEDCD9C0C0E"><enum>102.</enum><header>Coordinating research on chronic kidney disease</header> 
<subsection id="H49F39FA5DD6F479B9DEE93C91607564D"><enum>(a)</enum><header>Interagency committee</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services shall establish and maintain an interagency committee for the purpose of improving the coordination of chronic kidney disease research.</text> </subsection> <subsection id="HD589686504A841D4B134981290E55673"><enum>(b)</enum><header>Reports</header><text>For the purpose described in subsection (a), the interagency committee established under such subsection shall issue public reports that—</text> 
<paragraph id="H894D0DD1CF5B4C3BB8A08D3F82B2A479"><enum>(1)</enum><text>include a strategic plan, including recommendations for—</text> <subparagraph id="H02D9A6FADCBE4ABF853800E6B3299877"><enum>(A)</enum><text>improving communication and coordination among Federal agencies;</text> </subparagraph>
<subparagraph id="H49429C5B09FF4D378366426F913D0791"><enum>(B)</enum><text>procedures for monitoring Federal chronic kidney disease research activities; and</text> </subparagraph> <subparagraph id="HACF0086E208743E68BDA262B6DB773AF"><enum>(C)</enum><text>ways to maximize the efficiency of the Federal chronic kidney disease research investment and minimize the potential for unnecessary duplication;</text> </subparagraph></paragraph>
<paragraph id="HDFB9D3ECE6374218A565D9CF394FE57E"><enum>(2)</enum><text>include a portfolio analysis that provides information on chronic kidney disease research projects, organized by the strategic plan objectives; and</text> </paragraph> <paragraph id="H3111D7A54EDB4C2D9B71F8BDC8276864"><enum>(3)</enum><text>address such other topics as the interagency committee determines appropriate.</text> </paragraph></subsection>
<subsection id="HE144CF76950B4A90A5303EAF7B4D0842"><enum>(c)</enum><header>Meetings</header><text>The interagency committee established under subsection (a) shall meet not less than semi-annually.</text> </subsection></section> <section id="H9FE9A2C2D01443499BFA14E38605328F"><enum>103.</enum><header>Understanding the progression of kidney disease and treatment of kidney failure in minority populations</header><text display-inline="no-display-inline">Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services shall—</text> 
<paragraph id="HE9C5F716CAB9451EB74FD2BCD09E08EF"><enum>(1)</enum><text>complete a study on—</text> <subparagraph id="H804D360CCD6448F18BC507A14C5D2E89"><enum>(A)</enum><text>the social, behavioral, and biological factors leading to kidney disease;</text> </subparagraph>
<subparagraph id="H3DE54E0CB87B41EA9419BA93E959E076"><enum>(B)</enum><text>efforts to slow the progression of kidney disease in minority populations that are disproportionately affected by such disease; and</text> </subparagraph> <subparagraph id="H97578DFD57844B32B11D536E7EDFCA30"><enum>(C)</enum><text>treatment patterns associated with providing care, under the Medicare program under title XVIII of the Social Security Act, the Medicaid program under title XIX of such Act, and through private health insurance, to minority populations that are disproportionately affected by kidney failure; and</text> </subparagraph></paragraph>
<paragraph id="H3FACDCBB9B404571889551A3FC834C04"><enum>(2)</enum><text>submit a report to the Congress on the results of such study.</text> </paragraph></section></title> <title id="HB190DA462D7A480085BA72AECC1CA9D2"><enum>II</enum><header>Promoting Access to Chronic Kidney Disease Treatments</header> <section id="H47BF2D6CEEB74012B29352667B64C832"><enum>201.</enum><header>Increasing access to Medicare kidney disease education benefit</header> <subsection id="H8BA71FBC2AEE43E79CCC424B8DEAD675"><enum>(a)</enum><header>In general</header><text>Section 1861(ggg) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395x">42 U.S.C. 1395x(ggg)</external-xref>) is amended—</text> 
<paragraph id="H04451C5BA42F4F2A9072369AC8128C41"><enum>(1)</enum><text>in paragraph (1)—</text> <subparagraph id="H34FD086B95104A0BB46A19683E077D0E"><enum>(A)</enum><text display-inline="yes-display-inline">in subparagraph (A), by inserting <quote> or stage V</quote> after <quote>stage IV</quote>; and</text> </subparagraph>
<subparagraph id="HBCC05E1BFEB849DFB3C261E760F5A759"><enum>(B)</enum><text display-inline="yes-display-inline">in subparagraph (B), by inserting <quote>or of a physician assistant, nurse practitioner, or clinical nurse specialist (as defined in section 1861(aa)(5)) assisting in the treatment of the individual’s kidney condition</quote> after <quote>kidney condition</quote>; and</text> </subparagraph></paragraph> <paragraph id="HD2ED5963541048BAAC002ABE914514AB"><enum>(2)</enum><text>in paragraph (2)—</text> 
<subparagraph id="H3C064385CE924AFF910BB538A2A37AA4"><enum>(A)</enum><text>by striking subparagraph (B); and</text> </subparagraph> <subparagraph id="H1F071E94F5C74ADEBB605A2099365F6D"><enum>(B)</enum><text>in subparagraph (A)—</text> 
<clause id="HFCA60384B93D486BA1CD5F4ADF9DB1F2"><enum>(i)</enum><text>by striking <quote>(A)</quote> after <quote>(2)</quote>;</text> </clause> <clause id="H9012B6EDB0624C4390ED04F7BDA58191"><enum>(ii)</enum><text>by striking <quote>and</quote> at the end of clause (i);</text> </clause>
<clause id="H0B6B56537C2248FF84FFE6434DDB6A89"><enum>(iii)</enum><text>by striking the period at the end of clause (ii) and inserting <quote>; and</quote>;</text> </clause> <clause id="HEC83BBF263F04343BBA4B45FB8F4F987"><enum>(iv)</enum><text>by redesignating clauses (i) and (ii) as subparagraphs (A) and (B), respectively; and</text> </clause>
<clause id="H5765B87422544BEEAFD922B77BDA6145"><enum>(v)</enum><text>by adding at the end the following:</text> <quoted-block id="H73F7F1F48E43444BAEC431CEAC196976" style="OLC"> <subparagraph id="H857A6CD82FF443829766808A99FED9FD"><enum>(C)</enum><text>a renal dialysis facility subject to the requirements of section 1881(b)(1) with personnel who—</text> 
<clause id="HE5263279DD19426B81AAAA8BAA54920F"><enum>(i)</enum><text>provide the services described in paragraph (1); and</text> </clause> <clause id="HB0C8AA8716A54E2897771CA5B3AAA41A"><enum>(ii)</enum><text>is a physician (as defined in subsection (r)(1)) or a physician assistant, nurse practitioner, or clinical nurse specialist (as defined in subsection (aa)(5)).</text></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block> </clause></subparagraph></paragraph></subsection>
<subsection id="H3438B8239BF84C33A3DE87F5F037E498"><enum>(b)</enum><header>Payment to renal dialysis facilities</header><text>Section 1881(b) of such Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395rr">42 U.S.C. 1395rr(b)</external-xref>) is amended by adding at the end the following new paragraph:</text> <quoted-block id="HF1607E0ED9C942289ACBF4927F3C23E0" style="OLC"> <paragraph id="H7D28299473E449BD9CEE5ABB03964E3E"><enum>(15)</enum><text>For purposes of paragraph (14), the single payment for renal dialysis services under such paragraph shall not take into account the amount of payment for kidney disease education services (as defined in section 1861(ggg)). Instead, payment for such services shall be made to the renal dialysis facility on an assignment-related basis under section 1848.</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block> </subsection>
<subsection id="H78DDAFB1446149479CD2CE4B55375197"><enum>(c)</enum><header>Effective date</header><text>The amendments made by this section apply to kidney disease education services furnished on or after January 1, 2016.</text> </subsection></section> <section id="HF1361AB34784472F853ABEF7E766EFB6"><enum>202.</enum><header>Improving access to chronic kidney disease treatment in underserved rural and urban areas</header> <subsection id="H489655D258F24F719EB43090953D0203"><enum>(a)</enum><header>Definition of primary care services</header><text display-inline="yes-display-inline">Section 331(a)(3)(D) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/254d">42 U.S.C. 254d(a)(3)(D)</external-xref>) is amended by inserting <quote>and includes renal dialysis services</quote> before the period at the end.</text> </subsection>
<subsection id="HAA9A3B7A4F4142BC97E558CFC7733699"><enum>(b)</enum><header>National Health Service Corps Scholarship Program</header><text display-inline="yes-display-inline">Section 338A(a)(2) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/254l">42 U.S.C. 254l(a)(2)</external-xref>) is amended by inserting <quote>, including nephrologists and non-physician practitioners providing renal dialysis services</quote> before the period at the end.</text> </subsection> <subsection id="HD1CC85305A754F708694776CB9259E9B"><enum>(c)</enum><header>National Health Service Corps Loan Repayment Program</header><text display-inline="yes-display-inline">Section 338B(a)(2) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/254l-1">42 U.S.C. 254l–1(a)(2)</external-xref>) is amended by inserting <quote>, including nephrologists and non-physician practitioners providing renal dialysis services</quote> before the period at the end.</text> </subsection></section>
<section commented="no" id="H01827EC474C447CABDD754693EFF1E6D"><enum>203.</enum><header>Promoting access to home dialysis treatments</header><text display-inline="no-display-inline">Section 1834(m)(4)(C)(ii) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395m">42 U.S.C. 1395m(m)(4)(C)(ii)</external-xref>) is amended by adding at the end the following new subclause:</text> <quoted-block display-inline="no-display-inline" id="H2684642647304E98AFB81A8149F99AB7" style="OLC"> <subclause commented="no" id="H0BE18F306F4A425FA0592264F186B4A0"><enum>(IX)</enum><text display-inline="yes-display-inline">A renal dialysis facility (as defined in section 1881).</text></subclause><after-quoted-block>.</after-quoted-block></quoted-block> </section>
<section commented="no" id="H5DE5E78662404F4FA16D378377C4680C"><enum>204.</enum><header>Expand access for patients with acute kidney injury</header><text display-inline="no-display-inline">Section 1881(b) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395rr">42 U.S.C. 1395rr(b)</external-xref>) is amended—</text> <paragraph commented="no" id="H03187DBE2D634643B74AD4525EAAE43D"><enum>(1)</enum><text>in paragraph (1), by inserting <quote>or acute kidney injury</quote> after <quote>individuals who have been determined to have end stage renal disease</quote>;</text> </paragraph>
<paragraph commented="no" id="H623D77273A8C453DBFBDCA467EFB81EE"><enum>(2)</enum><text display-inline="yes-display-inline">in paragraph (2)(A), by inserting <quote>or acute kidney injury</quote> after <quote>end stage renal disease</quote>;</text> </paragraph> <paragraph commented="no" id="H25A815D505254209A6B179124CEF98A4"><enum>(3)</enum><text display-inline="yes-display-inline">in paragraph (2)(B), by inserting <quote>or acute kidney injury</quote> after <quote>end stage renal disease</quote>;</text> </paragraph>
<paragraph id="H8F04B403D2C0491E84432F28D1B5C52D"><enum>(4)</enum><text>in paragraph (3), in the matter preceding subparagraph (A), by inserting <quote>or acute kidney injury</quote> after <quote>end stage renal disease</quote>;</text> </paragraph> <paragraph id="HAF1A4C682BCF4C40ACBC806B4D26BA46"><enum>(5)</enum><text display-inline="yes-display-inline">in paragraph (11)(A), by inserting <quote>or acute kidney injury</quote> after <quote>end stage renal disease</quote>;</text> </paragraph>
<paragraph commented="no" id="HC2CBFCCD9A834F15828EE04689051E98"><enum>(6)</enum><text display-inline="yes-display-inline">in paragraph (11)(B), by inserting <quote>or acute kidney injury</quote> after <quote>end stage renal disease</quote>;</text> </paragraph> <paragraph id="H79BFA28C26F041B0971FBA44ADBD72DE"><enum>(7)</enum><text display-inline="yes-display-inline">in paragraph (14)(B)—</text> 
<subparagraph id="HEF5336A9174D4790A505697A4A4C99DE"><enum>(A)</enum><text display-inline="yes-display-inline">in clause (ii), by inserting <quote>or acute kidney injury</quote> after <quote>end stage renal disease</quote>;</text> </subparagraph> <subparagraph id="H023A5314F9CD49BB80E86F5403E6E388"><enum>(B)</enum><text display-inline="yes-display-inline">in clause (iii), by inserting <quote>or acute kidney injury</quote> after <quote>end stage renal disease</quote>; and</text> </subparagraph>
<subparagraph id="H818DC01E9385447F8E0184F78CA9E09B"><enum>(C)</enum><text display-inline="yes-display-inline">in clause (iv), by inserting <quote>or acute kidney injury</quote> after <quote>end stage renal disease</quote>; and</text> </subparagraph></paragraph> <paragraph commented="no" id="H521DF48A9BBD4FF6B7607BBFB0AFAD3A"><enum>(8)</enum><text display-inline="yes-display-inline">in paragraph (14)(H)(i), by inserting <quote>or acute kidney injury</quote> after <quote>end stage renal disease</quote>.</text> </paragraph></section></title>
<title commented="no" id="HF261E365714144ADA06149CA205790B0"><enum>III</enum><header>Creating Economic Stability for Providers Caring for Individuals with Chronic Kidney Disease</header> 
<section commented="no" id="HFA655311481247E2A83F152523A2EBA6"><enum>301.</enum><header>Stabilizing Medicare payments for services provided to beneficiaries with stage V chronic kidney disease receiving dialysis services</header><text display-inline="no-display-inline">Section 1881(b)(14) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395rr">42 U.S.C. 1395rr(b)(14)</external-xref>) is amended—</text> <paragraph commented="no" id="H014BBF4EF6D843878806791851485B5A"><enum>(1)</enum><text>in subparagraph (D), in the matter preceding clause (i), by striking <quote>Such system</quote> and inserting <quote>Subject to subparagraph (J), such system</quote>; and</text> </paragraph>
<paragraph commented="no" id="H87274B1706FA495482ED1DFB25017A77"><enum>(2)</enum><text>by adding at the end the following new subparagraph:</text> <quoted-block display-inline="no-display-inline" id="H37206D021765497482E858054277D99E" style="OLC"> <subparagraph commented="no" id="HAB79252C12154568A6E7EA90D04B93E3" indent="up2"><enum>(J)</enum> <clause commented="no" display-inline="yes-display-inline" id="HD76D1DAE7F3D467B89A877609BB2FBDB"><enum>(i)</enum><text>For payment for renal dialysis services furnished on or after January 1, 2016, under the system under this paragraph—</text> 
<subclause commented="no" id="HC89E065C734E4646AA044AA8C42E0ECA" indent="up1"><enum>(I)</enum><text>the payment adjustment described in clause (i) of subparagraph (D) shall not take into account comorbidities;</text> </subclause> <subclause commented="no" id="HE7D4875AB6434F8DAF5AF877ED5CD69F" indent="up1"><enum>(II)</enum><text>the payment adjustment described in clause (ii) of such subparagraph shall not be included;</text> </subclause>
<subclause commented="no" id="H87C024C85EAA4048BC1421ED0E88D0B0" indent="up1"><enum>(III)</enum><text>the standardization factor described in the final rule published in the Federal Register on November 8, 2012 (77 Fed. Reg. 67470), shall be established using the most currently available data (and not historical data) and adjusted on an annual basis, based on such available data, to account for any change in utilization of drugs and any modification in adjustors applied under this paragraph; and</text> </subclause> <subclause id="H3738878E99364F3DBE472763DB78BE8E" indent="up1"><enum>(IV)</enum><text display-inline="yes-display-inline">the Secretary shall take into account reasonable costs consistent with paragraph (2)(B) when calculating such payments.</text> </subclause></clause>
<clause commented="no" id="HABEB2695A7904F41A65422DFDAFB6919" indent="up1"><enum>(ii)</enum><text>Not later than January 1, 2016, the Secretary shall amend the ESRD facility cost report to—</text> <subclause commented="no" id="H0125EB1C9DC94146B37FE87E0A931947"><enum>(I)</enum><text>include the per treatment network fee (as described in paragraph (7)) as an allowable cost; and</text> </subclause>
<subclause commented="no" id="HF40B4A40F2BD4D8AAA77A19D001C0754"><enum>(II)</enum><text>eliminate the limitation for reporting medical director fees on such reports in order to take into account the wages of a board-certified nephrologist.</text></subclause></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block> </paragraph></section> <section commented="no" id="HE0222993C55A4EABA12784CFA1546340"><enum>302.</enum><header>Allowing individuals with kidney failure to retain access to private insurance</header> <subsection id="H7693D927902540FBB3D3C47BB90A91D6"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1862(b)(1)(C) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395y">42 U.S.C. 1395y(b)(1)(C)</external-xref>) is amended—</text> 
<paragraph commented="no" id="HCE17F12CBC174A3ABFFA5F20A03ACB19"><enum>(1)</enum><text>in the last sentence, by inserting <quote>and before January 1, 2016</quote> after <quote>prior to such date</quote>; and</text> </paragraph> <paragraph commented="no" id="HE89C3FE099314E2E943BBD4FAB29B170"><enum>(2)</enum><text>by adding at the end the following new sentence: <quote>Effective for items and services furnished on or after January 1, 2016 (with respect to periods beginning on or after the date that is 42 months prior to such date), clauses (i) and (ii) shall be applied by substituting <quote>42-month</quote> for <quote>12-month</quote> each place it appears.</quote>.</text> </paragraph></subsection>
<subsection id="H4F67A95051BE43628875C97D8EB34924"><enum>(b)</enum><header>Effective date</header><text display-inline="yes-display-inline">The amendments made by this subsection shall take effect on the date of enactment of this Act. For purposes of determining an individual’s status under section 1862(b)(1)(C) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395y">42 U.S.C. 1395y(b)(1)(C)</external-xref>), as amended by subsection (a), an individual who is within the coordinating period as of the date of enactment of this Act shall have that period extended to the full 42 months described in the last sentence of such section, as added by the amendment made by subsection (a)(2).</text> </subsection></section> <section commented="no" id="HBBFC4F6A05EA49EC94082F0B4473FBE7"><enum>303.</enum><header>Providing individuals with kidney failure access to managed care and coordinated care programs</header> <subsection commented="no" id="H68AD78A1664B4DA98D761ED38B785E9E"><enum>(a)</enum><header>Expanding access to Medicare Advantage</header> <paragraph commented="no" id="H6E2E288F6CD94E5C916F27CB95020C7C"><enum>(1)</enum><header>Eligibility under Medicare Advantage</header> <subparagraph commented="no" id="H7055FB3ADC1A45C1918E565F7335DC18"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1851(a)(3) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-21">42 U.S.C. 1395w–21(a)(3)</external-xref>) is amended—</text> 
<clause commented="no" id="HE14E6FDC25BA412D85F4BC316D168D83"><enum>(i)</enum><text>by striking subparagraph (B); and</text> </clause> <clause commented="no" id="H0FAAAC4A5B474D33B1CF554642E1C60B"><enum>(ii)</enum><text>by striking <quote><header-in-text level="paragraph" style="OLC">eligible individual.—</header-in-text></quote> and all that follows through <quote>In this title</quote> and inserting <quote><header-in-text level="paragraph" style="OLC">eligible individual.—</header-in-text>In this title</quote>.</text> </clause></subparagraph>
<subparagraph commented="no" id="H9696E7751A744D10BAE3C2D44EFC81D1"><enum>(B)</enum><header>Conforming amendment</header><text>Section 1852(b)(1) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-22">42 U.S.C. 1395w–22(b)(1)</external-xref>) is amended—</text> <clause commented="no" id="HAA9E3985334B4DF7B2FDC46FE961E08B"><enum>(i)</enum><text>by striking subparagraph (B); and</text> </clause>
<clause commented="no" id="H26F1F47471CB426E9854779CA2871E02"><enum>(ii)</enum><text>by striking <quote><header-in-text level="paragraph" style="OLC">Beneficiaries.—</header-in-text></quote> and all that follows through <quote>A Medicare+Choice organization</quote> and inserting <quote><header-in-text level="paragraph" style="OLC">Beneficiaries.—</header-in-text>A Medicare Advantage organization</quote>.</text> </clause></subparagraph> <subparagraph id="H89DA3B4940974432AFFA1BC4DDD5CE3B"><enum>(C)</enum><header>Effective date</header><text>The amendments made by this paragraph shall apply with respect to plan years beginning on or after January 1, 2016.</text> </subparagraph></paragraph>
<paragraph commented="no" id="HAA97489CB6E44E2091B2580B9CB58DEF"><enum>(2)</enum><header>Education</header><text display-inline="yes-display-inline">Section 1851(d)(2)(A)(iii) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-21">42 U.S.C. 1395w–21(d)(2)(A)(iii)</external-xref>) is amended by inserting before the period at the end the following <quote>, including any additional information that individuals determined to have end stage renal disease may need to make informed decisions with respect to such an election</quote>.</text> </paragraph> <paragraph commented="no" id="H2E35D7D259E3451C8398D37E6957383A"><enum>(3)</enum><header>Quality metrics</header><text display-inline="yes-display-inline">Section 1852(e)(3)(A) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-22">42 U.S.C. 1395w–22(e)(3)(A)</external-xref>) is amended by adding at the end the following new clause:</text> 
<quoted-block display-inline="no-display-inline" id="H65BBD42398104EADB243201A1383D439" style="OLC"> 
<clause commented="no" id="H9307C48CB4EC47CE8273F62819755CE4"><enum>(v)</enum><header>Requirements with respect to individuals with ESRD</header><text display-inline="yes-display-inline">In addition to the data required to be collected, analyzed, and reported under clause (i) and notwithstanding the limitations under subparagraph (B), as part of the quality improvement program under paragraph (1), each MA organization shall provide for the collection, analysis, and reporting of data, determined in consultation with the kidney care community, that permits the measurement of health outcomes and other indices of quality with respect to individuals determined to have end stage renal disease.</text></clause><after-quoted-block>.</after-quoted-block></quoted-block> </paragraph></subsection> <subsection display-inline="no-display-inline" id="H5E14EC6256B84D2DB255182EB7421B18"><enum>(b)</enum><header>Permanent extension of Medicare Advantage ESRD Special Needs Plans authority</header><text display-inline="yes-display-inline">Section 1859(f)(1) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-28">42 U.S.C. 1395w–28(f)(1)</external-xref>) is amended by inserting <quote>, in the case of a specialized MA plan for special needs individuals who have not been determined to have end stage renal disease,</quote> before <quote>for periods before January 1, 2017</quote>.</text> </subsection>
<subsection id="HF955BBB93CEE452FA89F9E19D417DB3F"><enum>(c)</enum><header>Voluntary ESRD coordinated care gainsharing program</header> 
<paragraph id="H562FDCA7648943FEA3E1D854236CAC6C"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1881(b) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395rr">42 U.S.C. 1395rr(b)</external-xref>) is amended by adding at the end the following new paragraph:</text> <quoted-block display-inline="no-display-inline" id="H10E8566CCF044A0B94F25F9396C724BF" style="OLC"> <paragraph id="HF4AC560AA9F8498D87F337EF65C9CE0F" indent="up1"><enum>(15)</enum> <subparagraph commented="no" display-inline="yes-display-inline" id="HC650B499CFD94C189DC78151F9C82E25"><enum>(A)</enum><text display-inline="yes-display-inline">Not later than January 1, 2017, the Secretary shall, in accordance with this paragraph, establish an ESRD Care Coordination gainsharing program for nephrologists, renal dialysis facilities, and providers of services that develop coordinated care organizations to provide a full range of clinical and supportive services (as described in subparagraph (D)) to individuals determined to have end stage renal disease.</text> </subparagraph>
<subparagraph id="H581A1B0FDCA34B7EB953D5CF95B9A83A" indent="up1"><enum>(B)</enum><text>Under such program, subject to subparagraph (C), the payment amounts renal dialysis facilities and providers of services described in subparagraph (A) would otherwise receive under paragraph (14) and nephrologists described in subparagraph (A) would otherwise receive under section 1848 with respect to dialysis services furnished by such a facility, provider, or nephrologist during a year, shall be increased by a portion of the amount (as determined by the Secretary) of actual reductions in expenditure under this title attributable to the coordinated care organization developed by such facility, provider, or nephrologist involved, taking into account non-dialysis expenditures under parts A and B, during the preceding calendar year. The payment amount under this subparagraph shall be provided to a nephrologist, renal dialysis facility, and provider of services that developed the coordinated care organization no later than March 31 of the year after the year during which such services are provided by such nephrologist, facility, or provider.</text> </subparagraph> <subparagraph id="H67AFCF96DD864558969EF9AC140C7717" indent="up1"><enum>(C)</enum><text>The aggregate incentive payment amounts provided under such program for a year may not exceed the amount equal to 2 percent less than the estimated total amount of non-dialysis expenditures under parts A and B for 2016 for items and services that are not related to dialysis or transplant services.</text> </subparagraph>
<subparagraph id="H510F0A27351B496DBB05F368639486B1" indent="up1"><enum>(D)</enum><text>For purposes of subparagraph (A), the full range of clinical and supportive services includes at least the following:</text> <clause id="HFFA360A846004BD2AF43D88B1CB8D7C4"><enum>(i)</enum><text>Primary care and other preventative services.</text> </clause>
<clause id="HCD6D81F1DEE64440BDF983F10C4F1E5C"><enum>(ii)</enum><text>Specialty care for co-morbidities or non-renal acute conditions, including at least podiatry, cardiology, and orthopedics.</text> </clause> <clause id="HDBF20B8773564391B2FD0E4882205311"><enum>(iii)</enum><text>Vascular access.</text> </clause>
<clause id="H64368ACB2E72490AB99127FFDF108351"><enum>(iv)</enum><text>Laboratory testing and diagnostic imaging.</text> </clause> <clause id="HE5E05168BCA0482F9025C91366FEB85F"><enum>(v)</enum><text>Pharmacy care management.</text> </clause>
<clause id="HFF482B830AE54823955434EE6F95862D"><enum>(vi)</enum><text>Patient, family, and caregiver education.</text> </clause> <clause id="HF8FDFC3DD50B4184943CD9F859663E06"><enum>(vii)</enum><text>Psychiatric, behavioral therapy, and counseling services.</text> </clause></subparagraph>
<subparagraph commented="no" id="HA7E6378BF367455DBA356A40BB7B8D9C" indent="up1"><enum>(E)</enum><text>In providing payment incentive amounts under such program, the Secretary shall apply a risk adjustment methodology that—</text> <clause commented="no" id="HD092AF58DB0447988901130657644D83"><enum>(i)</enum><text>uses risk adjuster factors applied under part C; and</text> </clause>
<clause commented="no" id="H70BA9DD5DF454478B0BFED456B9F0C00"><enum>(ii)</enum><text>adjusts such payments to exclude the top 2 percent of outliers.</text> </clause></subparagraph> <subparagraph id="H1A096E6129EF41ABB95BD77125F854B0" indent="up1"><enum>(F)</enum><text>In establishing such program, the Secretary shall ensure that each of the following is satisfied:</text> 
<clause id="H4A4AA1959DFB40378A1E18ED357DB203"><enum>(i)</enum><text>The program allows for all types and sizes of renal dialysis facilities and providers of services described in subparagraph (A), including profit and not-for-profit, urban and rural, as well as all other types and sizes of such facilities and providers, to participate.</text> </clause> <clause id="H4D0C76E249224581A5A9641A8443EB7D"><enum>(ii)</enum><text display-inline="yes-display-inline">The program rewards high quality, efficient facilities and providers through gain-sharing.</text> </clause>
<clause id="HD26A8741B6FB4C9788490810156A22B3"><enum>(iii)</enum><text display-inline="yes-display-inline">For purposes of determining the actual reductions in expenditures under this title attributable to a coordinated care organization described in subparagraph (A), the program includes a market-based benchmark system that will not be rebased against which such expenditures shall be compared.</text> </clause> <clause id="H5864162D926A411CB08E688420079A94"><enum>(iv)</enum><text display-inline="yes-display-inline">The program results in reductions of expenditures under parts A and B for services that are not dialysis-related services.</text> </clause>
<clause id="HC8FD33955DA04313880577E12C08AC2F"><enum>(v)</enum><text display-inline="yes-display-inline">The program allows new applicants to participate in the program after the initial implementation period.</text> </clause> <clause id="H943BACF994E2444E8E7A0BAEF5FC5B17"><enum>(vi)</enum><text display-inline="yes-display-inline">The program establishes clear quality metrics in consultation with the kidney care community.</text> </clause>
<clause id="HC9F62181B75E46B39D103D088D900D33"><enum>(vii)</enum><text display-inline="yes-display-inline">The program provides for waivers of Federal laws or requirements, in consultation with interested stakeholders.</text> </clause> <clause id="H342E4CF09A534DF9BB0D5A0CBE662180"><enum>(viii)</enum><text display-inline="yes-display-inline">Under such program the Secretary attributes individuals described in subparagraph (A) who receive treatment through a care coordination organization described in such subparagraph to such organization rather than to any other payment model that requires beneficiary attribution.</text> </clause>
<clause id="H969A5CF0B2D04D3E80A9F74DB756B0D7"><enum>(ix)</enum><text>Under such program the Secretary provides quarterly Medicare parts A and B claims data to facilities and providers described in subparagraph (A) participating in such program.</text> </clause></subparagraph> <subparagraph id="H0A89E29C406E4C9ABD5F0D53AF06EC9B" indent="up1"><enum>(G)</enum><text display-inline="yes-display-inline">Not later than three years after the date of the implementation of the ESRD Care Coordination gainsharing program, the Secretary shall submit to the Congress a report on the waivers granted under subparagraph (F)(vii) and the effectiveness of such waivers in allowing the coordination of care.</text></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block> </paragraph>
<paragraph id="HBF1BE2C330AE4563B744FC757292FCF2"><enum>(2)</enum><header>Conforming amendments</header> 
<subparagraph id="H84B6A5E89A3B4F5E9111DE23E550ED4F"><enum>(A)</enum><header>Section 1881</header><text display-inline="yes-display-inline">Section 1881(b) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395rr">42 U.S.C. 1395rr(b)</external-xref>) is amended—</text> <clause id="H2FA7330792E74BD4955D0750EC71C629"><enum>(i)</enum><text>in each of paragraphs (12)(A) and (13)(A), by striking <quote>paragraph (14)</quote> and inserting <quote>paragraphs (14) and (15)</quote>; and</text> </clause>
<clause id="HD7E1CB7E7D7844899AB85BCB957D4568"><enum>(ii)</enum><text>in paragraph (14)(A)(i), by inserting <quote>and paragraph (15)</quote> after <quote>Subject to subparagraph (E)</quote>.</text> </clause></subparagraph> <subparagraph id="HCD3044EBA28F4840A07D0512F6318795"><enum>(B)</enum><header>Section 1848</header><text>Section 1848 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-4">42 U.S.C. 1395w–4</external-xref>) is amended by adding at the end the following new subsection:</text> 
<quoted-block display-inline="no-display-inline" id="H650DD1A90948427F87DE490D5D7D9F1A" style="OLC"> 
<subsection id="HEBB0B3E1050D4ECFB0FE4D5319FF00B6"><enum>(q)</enum><header>Voluntary ESRD coordinated care program</header><text display-inline="yes-display-inline">For provisions related to incentive payment amounts to nephrologists under the ESRD Care Coordination gainsharing program, see section 1881(b)(15).</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block> </subparagraph></paragraph></subsection> <subsection commented="no" id="HF27275158C254B3D8BEBB1FDD793055A"><enum>(d)</enum><header>Patient information requirement</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services shall require hospitals that furnish items and services to individuals entitled to benefits under part A of title XVIII of the Social Security Act or eligible for benefits under part B of such title and who subsequently receive dialysis services at a renal dialysis facility (as defined in section 1881 of such Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395rr">42 U.S.C. 1395rr</external-xref>)) to provide to such facility health information with respect to such individual, including a discharge summary and co-morbidity information, upon request of the facility, not later than 7 days after notification by the hospital of the provision of such services to such individual or of the determination that such individual has end stage renal disease, as applicable.</text> </subsection></section></title>
</legis-body> 
</bill> 


